C5 and complement 3 glomerulopathy: Cfh−/− mice injected with anti-C5 antibodies before administration of nephrotoxic serum also were protected, suggesting that anti-C5 therapy may be beneficial in human beings with C3 glomerulopathy owing to Cfh deficiency (eg, during disease flares).